BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32148857)

  • 1. The structural study of mutation-induced inactivation of human muscarinic receptor M4.
    Wang J; Wu M; Wu L; Xu Y; Li F; Wu Y; Popov P; Wang L; Bai F; Zhao S; Liu ZJ; Hua T
    IUCrJ; 2020 Mar; 7(Pt 2):294-305. PubMed ID: 32148857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.
    Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M
    J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and Development of Muscarinic Acetylcholine M
    Takai K; Enomoto T
    Chem Pharm Bull (Tokyo); 2018; 66(1):37-44. PubMed ID: 29311510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological hallmarks of allostery at the M4 muscarinic receptor elucidated through structure and dynamics.
    Vuckovic Z; Wang J; Pham V; Mobbs JI; Belousoff MJ; Bhattarai A; Burger WAC; Thompson G; Yeasmin M; Nawaratne V; Leach K; van der Westhuizen ET; Khajehali E; Liang YL; Glukhova A; Wootten D; Lindsley CW; Tobin A; Sexton P; Danev R; Valant C; Miao Y; Christopoulos A; Thal DM
    Elife; 2023 May; 12():. PubMed ID: 37248726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the function of M4 muscarinic acetylcholine receptors gained using a novel allosteric modulator and a DREADD (designer receptor exclusively activated by a designer drug).
    Nawaratne V; Leach K; Suratman N; Loiacono RE; Felder CC; Armbruster BN; Roth BL; Sexton PM; Christopoulos A
    Mol Pharmacol; 2008 Oct; 74(4):1119-31. PubMed ID: 18628403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structures of the M1 and M4 muscarinic acetylcholine receptors.
    Thal DM; Sun B; Feng D; Nawaratne V; Leach K; Felder CC; Bures MG; Evans DA; Weis WI; Bachhawat P; Kobilka TS; Sexton PM; Kobilka BK; Christopoulos A
    Nature; 2016 Mar; 531(7594):335-40. PubMed ID: 26958838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
    Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
    Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Conserved Tyrosine Lid Residues in the Activation of the M
    Pham V; Habben Jansen MCC; Thompson G; Heitman LH; Christopoulos A; Thal DM; Valant C
    Mol Pharmacol; 2023 Sep; 104(3):92-104. PubMed ID: 37348914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xanomeline displays concomitant orthosteric and allosteric binding modes at the M
    Burger WAC; Pham V; Vuckovic Z; Powers AS; Mobbs JI; Laloudakis Y; Glukhova A; Wootten D; Tobin AB; Sexton PM; Paul SM; Felder CC; Danev R; Dror RO; Christopoulos A; Valant C; Thal DM
    Nat Commun; 2023 Sep; 14(1):5440. PubMed ID: 37673901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biased Profile of Xanomeline at the Recombinant Human M
    McDonald JK; van der Westhuizen ET; Pham V; Thompson G; Felder CC; Paul SM; Thal DM; Christopoulos A; Valant C
    ACS Chem Neurosci; 2022 Apr; 13(8):1206-1218. PubMed ID: 35380782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myopia-Inhibiting Concentrations of Muscarinic Receptor Antagonists Block Activation of Alpha2A-Adrenoceptors In Vitro.
    Carr BJ; Mihara K; Ramachandran R; Saifeddine M; Nathanson NM; Stell WK; Hollenberg MD
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2778-2791. PubMed ID: 29860464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural determinants of allosteric agonism and modulation at the M4 muscarinic acetylcholine receptor: identification of ligand-specific and global activation mechanisms.
    Nawaratne V; Leach K; Felder CC; Sexton PM; Christopoulos A
    J Biol Chem; 2010 Jun; 285(25):19012-21. PubMed ID: 20406819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric modulators targeting CNS muscarinic receptors.
    Bock A; Schrage R; Mohr K
    Neuropharmacology; 2018 Jul; 136(Pt C):427-437. PubMed ID: 28935216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Features of Iperoxo-BQCA Muscarinic Acetylcholine Receptor Hybrid Ligands Determining Subtype Selectivity and Efficacy.
    Wakeham MCL; Davie BJ; Chalmers DK; Christopoulos A; Capuano B; Valant C; Scammells PJ
    ACS Chem Neurosci; 2022 Jan; 13(1):97-111. PubMed ID: 34905693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents.
    Bubser M; Bridges TM; Dencker D; Gould RW; Grannan M; Noetzel MJ; Lamsal A; Niswender CM; Daniels JS; Poslusney MS; Melancon BJ; Tarr JC; Byers FW; Wess J; Duggan ME; Dunlop J; Wood MW; Brandon NJ; Wood MR; Lindsley CW; Conn PJ; Jones CK
    ACS Chem Neurosci; 2014 Oct; 5(10):920-42. PubMed ID: 25137629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of the M
    Moehle MS; Conn PJ
    Mov Disord; 2019 Aug; 34(8):1089-1099. PubMed ID: 31211471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats.
    Brugnoli A; Pisanò CA; Morari M
    Neurobiol Dis; 2020 Oct; 144():105044. PubMed ID: 32798726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholine Muscarinic M
    Walker LC; Berizzi AE; Chen NA; Rueda P; Perreau VM; Huckstep K; Srisontiyakul J; Govitrapong P; Xiaojian J; Lindsley CW; Jones CK; Riddy DM; Christopoulos A; Langmead CJ; Lawrence AJ
    Biol Psychiatry; 2020 Dec; 88(12):898-909. PubMed ID: 32331824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multitargeting nature of muscarinic orthosteric agonists and antagonists.
    Myslivecek J
    Front Physiol; 2022; 13():974160. PubMed ID: 36148314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of the First Selective M
    Moehle MS; Bender AM; Dickerson JW; Foster DJ; Qi A; Cho HP; Donsante Y; Peng W; Bryant Z; Stillwell KJ; Bridges TM; Chang S; Watson KJ; O'Neill JC; Engers JL; Peng L; Rodriguez AL; Niswender CM; Lindsley CW; Hess EJ; Conn PJ; Rook JM
    ACS Pharmacol Transl Sci; 2021 Aug; 4(4):1306-1321. PubMed ID: 34423268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.